Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Known antianginal agent claimed for use in retinal diseases by French researchers

May 9, 2000

Preliminary phase II results for Optin in AMD

May 9, 2000

Actin polymerization inducer jasplakinolide improves outflow facility in primate model

May 5, 2000

News from ARVO: ISV-205 reduces corticosteroid-induced IOP elevations

May 5, 2000

Final results of phase I/IIa trial evaluating CAT-152 in trabeculectomy patients announced at ARVO

May 5, 2000

News from ARVO: antiglaucoma activity of p160ROCK kinase inhibitor

May 3, 2000

Chiron team identifies promising treatment for retinitis pigmentosa

May 3, 2000

New formulations of carteolol may reduce dosing frequency

May 2, 2000

IOP-lowering efficacy of anecortave established in preclinical models and in patients

May 2, 2000

AMPA antagonist improves visual function in humans

May 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...